✦ LIBER ✦

A synthesis of cost-utility analysis literature in infectious disease

✍ Scribed by Patricia W Stone; Bruce R Schackman; Christopher P Neukermans; Natalia Olchanski; Dan Greenberg; Allison B Rosen; Peter J Neumann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment costs in hodgkin's disease: A

✍ J. Norum; V. Angelsen; E. Wist; J.A. Olsen 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 933 KB

PND32 Cost-Utility Analysis of Ropinirol

✍ I. Zerda; A. Drozdz; D. Brzyski; M. Pochopien; B. Gwiosda; B. Lisiecka; D. Barlo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-Utility Analysis of von Willebrand

✍ Robert Francis Sidonio Jr.; Kenneth J. Smith; Margaret V. Ragni 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 523 KB

PMC11 GROWTH, CHARACTERISTICS AND QUALIT

✍ D Greenberg; C Fang; JT Cohen; A Eldar-Lissai; PJ Neumann 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Cost-Utility Analysis of Disease-Modifyi

✍ Imani, A. (author);Golestani, M. (author);Tabrizi, J.S. (author);Janati, A. (aut 📂 Article 📅 2013 🏛 Elsevier BV 🌐 English ⚖ 60 KB

Cost-Utility Analysis of Disease-Modifyi

✍ Imani, A. (author);Golestani, M. (author);Tabrizi, J.S. (author);Janati, A. (aut 📂 Article 📅 2013 🏛 Elsevier BV 🌐 English ⚖ 60 KB